Company News

We are thrilled to announce the successful installation of South Korea’s first STYX high-throughput screening system at the Korea Advanced Institute of Science and Technology (KAIST). This milestone marks an exciting step in our mission to empower cutting-edge...

Vilnius, Lithuania – October 10, 2024 – Atrandi Biosciences, a pioneer in semi-permeable capsule (SPC) technology, is proud to announce the launch of its latest innovation in the SPC product line – the SPC Innovator Kit for 30 µm capsules generation...

Atrandi Biosciences Launches Proof-of-Concept Program for High-Throughput Single-Cell Microbial DNA Sequencing VILNIUS, Lithuania | February 2024 – Atrandi Biosciences has recently unveiled the Flux microfluidic system and the Single-Microbe DNA...

Atrandi Biosciences and Bigelow Laboratory's Single Cell Genomics Center (SCGC) have teamed up to complement the high-throughput single-cell microbial DNA sequencing workflow with bioinformatics services VILNIUS, Lithuania and BOOTHBAY, ME, US | February...

Project coordinator: VšĮ Innovation Agency Project partners: Kaunas University of Technology consortium (Vilnius Gediminas Technical University, Mykolas Romeris University, Association Infobalt, UAB Devslate Group, UAB Novian pro, Lithuanian Cybercrime...

VILNIUS, Lithuania | January 2024 – Atrandi Biosciences introduces Flux, an intuitive microfluidic platform, and the Single-Microbe DNA Barcoding Kit, supporting high-throughput microbial DNA sequencing. These innovations harness the power of Semi-Permeable...

VILNIUS, Lithuania | December 2023 – Atrandi Biosciences, an innovator in microfluidic tools, is delighted to announce a strategic alliance with Suremedical Inc., a prominent distributor of scientific devices in South Korea. This collaboration marks...

VILNIUS, Lithuania | November 2023 – Atrandi Biosciences recently participated at the Protein & Antibody Engineering Summit (PEGS) in Portugal, showcasing advancements in droplet microfluidics and semi-permeable capsule technologies. Zana Kapustina...

VILNIUS, Lithuania | October 2023 – Atrandi Biosciences had a noteworthy presence at the EMBO | EMBL Symposium: The Human Microbiome, hosting an exclusive pre-conference workshop as part of the event. The workshop, led by Senior Product Manager Linas...

VILNIUS, Lithuania | September 2023 – Atrandi Biosciences democratized SPC generation by launching a push-button microfluidic platform The Flux platform introduces a seamless parallelization capability, enabling simultaneous processing of up to 8

VILNIUS, Lithuania | August 2023 – Atrandi Biosciences is delighted to announce a strategic collaboration with the Technical University of Denmark's (DTU) National Food Institute, representing a significant stride in advancing microbial research

VILNIUS, Lithuania | July 2023 – Atrandi Bio, a leading provider of microfluidic solutions, has joined forces with 9X Bio, a well-established distributor in China, to solidify an exclusive distribution agreement. This collaboration marks a significant...

VILNIUS, Lithuania | June 2023 – Atrandi Biosciences Spotlights AMR Breakthroughs with Dr. Meilee Ling's (DTU) Presentation at BaGeCo 2023 Symposium Atrandi Biosciences participated in the 16th Symposium on Bacterial Genetics and Ecology (BaGeCo...

VILNIUS, Lithuania | May 2023 – Atrandi Biosciences, formerly known as Droplet Genomics, proudly announces a strategic distribution partnership with BIOKÉ for the BeNeLux region (Belgium, Netherlands, and Luxembourg). This collaboration marks a pivotal...

VILNIUS, Lithuania | April 2023 – Atrandi Biosciences, an emerging developer of innovative microfluidic solutions for the life sciences, is thrilled to announce the release of its groundbreaking Semi-Permeable Capsule (SPC) technology through the

VILNIUS, Lithuania | March 2023 – Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology VILNIUS, Lithuania and DENVER, CO, March 23, 2023 - Backed by international investors, Atrandi

VILNIUS, Lithuania | February 14, 2023 – Droplet Genomics, an emerging innovator and provider of microfluidic and single cell analysis technologies, announced today the appointment of Andy Watson as its Chairman of the Board of Directors. “We are...

VILNIUS, Lithuania | March 2023 – Droplet Genomics, a leading provider of innovative microfluidic solutions, is excited to announce that it has signed Labgene as its new distributor in Switzerland. This collaboration between two industry leaders will...

Dear Attendees, We are pleased to inform you that we will be participating in The Festival of Genomics & Biodata, to be held on January 25-26 at the Business Design Centre. Our booth, number TT8, will be located in the foyer outside the Main Stage and...